DK3330264T3 - Pyridin substitueret 2-aminopyridin proteinkinase-inhibitorkrystal - Google Patents

Pyridin substitueret 2-aminopyridin proteinkinase-inhibitorkrystal Download PDF

Info

Publication number
DK3330264T3
DK3330264T3 DK16829879.2T DK16829879T DK3330264T3 DK 3330264 T3 DK3330264 T3 DK 3330264T3 DK 16829879 T DK16829879 T DK 16829879T DK 3330264 T3 DK3330264 T3 DK 3330264T3
Authority
DK
Denmark
Prior art keywords
substitueret
inhibitorkrystal
proteinkinase
aminopyridin
pyridin
Prior art date
Application number
DK16829879.2T
Other languages
English (en)
Inventor
Feng Gong
Xinlu Li
Rui Zhao
Xiquan Zhang
Xinhe Xu
Xijie Liu
Dengming Xiao
Yongxin Han
Original Assignee
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Lianyungang Runzhong Pharmaceutical Co Ltd
Centaurus Biopharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chia Tai Tianqing Pharmaceutical Group Co Ltd, Lianyungang Runzhong Pharmaceutical Co Ltd, Centaurus Biopharma Co Ltd filed Critical Chia Tai Tianqing Pharmaceutical Group Co Ltd
Application granted granted Critical
Publication of DK3330264T3 publication Critical patent/DK3330264T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK16829879.2T 2015-07-30 2016-07-29 Pyridin substitueret 2-aminopyridin proteinkinase-inhibitorkrystal DK3330264T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201510458524 2015-07-30
PCT/CN2016/092269 WO2017016514A1 (zh) 2015-07-30 2016-07-29 吡啶取代的2-氨基吡啶类蛋白激酶抑制剂的结晶

Publications (1)

Publication Number Publication Date
DK3330264T3 true DK3330264T3 (en) 2020-06-02

Family

ID=57884126

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16829879.2T DK3330264T3 (en) 2015-07-30 2016-07-29 Pyridin substitueret 2-aminopyridin proteinkinase-inhibitorkrystal

Country Status (9)

Country Link
US (1) US10385038B2 (da)
EP (1) EP3330264B1 (da)
JP (1) JP6513294B2 (da)
CN (3) CN110330483A (da)
DK (1) DK3330264T3 (da)
HK (1) HK1250368B (da)
HU (1) HUE050352T2 (da)
TW (1) TWI707848B (da)
WO (1) WO2017016514A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016015676A1 (zh) * 2014-07-31 2016-02-04 正大天晴药业集团股份有限公司 吡啶取代的2-氨基吡啶类蛋白激酶抑制剂
CN114173785A (zh) * 2019-08-01 2022-03-11 正大天晴药业集团股份有限公司 用于治疗非小细胞肺癌的氨基吡啶衍生物
CN115484955A (zh) * 2020-04-30 2022-12-16 正大天晴药业集团股份有限公司 用于治疗met基因异常疾病的氨基吡啶衍生物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008510792A (ja) 2004-08-26 2008-04-10 ファイザー・インク タンパク質チロシンキナーゼ阻害剤としてのアミノヘテロアリール化合物
PT2952510T (pt) 2013-02-02 2019-04-16 Centaurus Biopharma Co Ltd Inibidor de proteína-cinase de 2-aminopiridina substituída
CN103965161A (zh) * 2013-02-02 2014-08-06 正大天晴药业集团股份有限公司 取代的2-氨基吡啶类蛋白激酶抑制剂
WO2016015676A1 (zh) * 2014-07-31 2016-02-04 正大天晴药业集团股份有限公司 吡啶取代的2-氨基吡啶类蛋白激酶抑制剂
KR102203025B1 (ko) * 2014-08-06 2021-01-14 엘지이노텍 주식회사 탄화규소 에피 웨이퍼 제조 방법

Also Published As

Publication number Publication date
HK1250368B (zh) 2020-05-22
CN110283161A (zh) 2019-09-27
WO2017016514A1 (zh) 2017-02-02
TWI707848B (zh) 2020-10-21
US20180244649A1 (en) 2018-08-30
EP3330264A4 (en) 2019-01-09
JP6513294B2 (ja) 2019-05-15
TW201704226A (zh) 2017-02-01
EP3330264A1 (en) 2018-06-06
CN110330483A (zh) 2019-10-15
CN107949560B (zh) 2019-08-16
JP2018522067A (ja) 2018-08-09
EP3330264B1 (en) 2020-05-06
US10385038B2 (en) 2019-08-20
CN110283161B (zh) 2021-09-03
CN107949560A (zh) 2018-04-20
HUE050352T2 (hu) 2020-11-30

Similar Documents

Publication Publication Date Title
DK3389557T3 (en) Transseptalt leveringssystem
DK3320033T3 (en) Polyethylenterephthalat-depolymerisering
DK3256579T3 (en) Cysteinprotease
DK3256580T3 (en) Cysteinprotease
DK3298030T3 (en) Anti-cancerfusionspolypeptid
DK3250592T3 (en) Anti-transthyretin-antistoffer
DK3373882T3 (en) Patientisolator
GB2538731B (en) Methods
DK3284069T3 (en) Pos-terminal
DK3390996T3 (en) Trykbart tids-temperaturindikatorsystem
GB201518762D0 (en) Methods
DK3380145T3 (en) Injektionsapparat
DK3336185T3 (en) Antistof
DK3272750T3 (en) Morphinan-derivat
DK3324768T3 (en) Tørdragt
AU361999S (en) Ballustrade
ZA201701783B (en) Pyridine compounds
GB201508927D0 (en) Methods
DK3330264T3 (en) Pyridin substitueret 2-aminopyridin proteinkinase-inhibitorkrystal
DK3133099T3 (en) Polymermodificeret polyoldispersion
GB201515655D0 (en) Methods
DK3282866T3 (en) Proteinfibre
DK3250312T3 (en) Urea-metalnitrat-scr-system
DK3294653T3 (en) Justerbar inline-port
DK3242882T3 (en) Cgrp-antagonistpeptider